-+ 0.00%
-+ 0.00%
-+ 0.00%

Rocket Pharmaceuticals Announces FDA Acceptance of BLA Resubmission for KRESLADI™ Gene Therapy for Severe LAD-I; PDUFA Date Set for March 2026

Reuters·10/14/2025 11:00:57

Please log in to view news